BlackRock, Inc.

Position in JNJ — Johnson & Johnson

CIK 2012383 New York, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$53,866,596,097

+$1,706,633,245 QoQ

Shares Held

212,098,264

-0.6% QoQ

Ownership

8.80%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

of 4,676 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $263,330,305,956 across 19 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	67,540,400	$81,009,988,717
2	JNJ	Johnson & Johnson This page	212,098,264	$53,866,596,097
3	ABBV	AbbVie Inc.	149,488,412	$37,617,263,984
4	MRK	Merck & Co., Inc.	226,999,837	$29,169,479,049
5	AMGN	Amgen Inc	49,362,016	$17,874,973,223
6	GILD	Gilead Sciences, Inc.	121,844,108	$15,393,784,591
7	PFE	Pfizer Inc	529,670,433	$12,754,464,016
8	BMY	Bristol Myers Squibb Co	180,384,994	$10,393,783,345

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,866,596,097	212,098,264	-0.6%	Shares	Sole	2026-08-07
2026-03-31	$52,159,962,852	213,385,546	+2.2%	Shares	Sole	2026-05-13
2025-12-31	$43,207,260,845	208,781,159	+0.7%	Shares	Sole	2026-02-12
2025-09-30	$38,430,338,501	207,261,021	+1.7%	Shares	Sole	2025-11-12
2025-06-30	$31,137,977,818	203,849,282	+2.2%	Shares	Sole	2025-08-12
2025-03-31	$33,063,016,469	199,366,959	-1.0%	Shares	Sole	2025-05-02
2024-12-31	$29,116,575,837	201,331,599	+0.7%	Shares	Sole	2025-02-07
2024-09-30	$32,404,299,222	199,952,482	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.